Pragya D. Yadav
Born (1978-07-01) 1 July 1978
Sant Kabir Nagar, Uttar Pradesh, India
NationalityIndian
Other namesPD Yadav
Pragya Dhruv Yadav
Citizenship India
EducationB.Sc., M.Sc., Ph.D.
Alma materDr. Ram Manohar Lohia Avadh University
University of Pune
Known forResearch contributions in the field of communicable diseases and pathogenic viral infections.
Animal studies to develop Covid-19 vaccines Covaxin and ZyCoV-D in India.
AwardsBharat Bhagya Vidhata Award by Ministry of Culture (2022)
NAMS's Dr. Vinod Kumar Bhargava Award (2021)
ICMR's Major General Saheb Singh Sokhey Award (2017)
ICMR's Dr. T Ram Chandra Rao Award (2012)
Scientific career
FieldsMolecular biology
Virology
Biocontainment

Pragya D. Yadav (born 1 July 1978) is an Indian scientist at the ICMR-National Institute of Virology (NIV), who is known for her research contributions in the field of communicable diseases and highly pathogenic viral infections, such as Crimean–Congo hemorrhagic fever (CCHF), Nipah, Ebola, leading to improvising national public health surveillance policy for interventions and management. Yadav is among the scientists who detected the first three COVID-19 pandemic cases in India.[1][2][3] She headed the team that developed Covaxin, the first indigenous COVID-19 vaccine in India [4]

She was conferred the 2017 Major Gen Saheb Singh Sokhey Award in October 2019 by the Indian Council of Medical Research, Ministry of Health and Family Welfare.[5] She was selected as fellow of the Centers for Disease Control and Prevention, USA, Japan International Cooperation Agency, Japan. She was elected fellow of the National Academy of Agricultural Sciences, India.[6]

Early life and career

She was born on 1 July 1978, in Kui Kol, Sant Kabir Nagar district, in the North Indian state of Uttar Pradesh. She studied at Sarswati Shishu Mandir in Tanda, Ambedkar Nagar, from 1984 to 1989 and attended Vidyut Parishad Intermediate College, Tanda, from 1989 to 1995. She holds a B.Sc. from Dr. Ram Manohar Lohia Avadh University. She completed a Doctoral degree at the ICMR-National Institute of Virology in affiliation with the University of Pune in 2004.[7]

Work

Yadav joined ICMR-National Institute of Virology in 2003. In 2006, she traveled to the Centers for Disease Control and Prevention, USA, for Biosafety level four laboratory (BSL 4) management training. After returning from the US, she was involved in setting up the BSL 4 lab at NIV, which was operationalized in 2013.[8] She is in-charge of Biosafety level 4 (BSL 4) laboratory at the National Institute of Virology (NIV). Yadav was instrumental in isolating the SARS-CoV-2 virus and conducting animal studies to develop indigenous Covid-19 vaccines Covaxin and ZyCoV-D.[6] She has expertise in Crimean-Congo hemorrhagic fever, Nipah, Ebola, Hantaan orthohantavirus, Kyasanur Forest disease, Viral hemorrhagic fever and Severe Acute Respiratory Syndrome coronavirus. Her clinical research includes co-authoring 226 peer-reviewed articles in the past 17 years.[9]

Yadav is a member of the Advisory Council of the International Society on Crimean-Congo Hemorrhagic Fever in 2017. She is a Task Force member of the Coalition for Epidemic Preparedness Innovations (CEPI) Standards Assays Nipah in 2019. She is also a member of the WHO SEARO Expert Reference Group on the Nipah virus in 2020.[6]

In one of her research studies published in April 2022 by the Indian Journal of Medical Research, in which she wrote that there is no evidence to claim that bat coronaviruses can cause disease in humans and also bat coronaviruses have no relation with SARS-CoV-2 responsible for the COVID-19 pandemic.[10]

Awards and recognition

Pragya D Yadav was awarded the Bharat Bhagya Vidhata Award by the Ministry of Culture (India) in March 2022. The award was presented by the former Union health minister J. P. Nadda at the Red Fort.[6] The National Academy of Medical Sciences conferred the Dr. Pran Nath Chhuttani Oration Award for 2021-2022.[11] She was awarded the Dr. K.M. Bhansali Oration award by the Indian Association of Occupational Health, Mumbai, in 2021[7] followed by the Dr. Vinod Kumar Bhargava Award by the National Academy of Medical Sciences in the same year.[7] In October 2019, Yadav was honoured with the Major General Saheb Singh Sokhey Award 2017 by the Indian Council of Medical Research for research on the public health importance of Crimean-Congo Hemorrhagic Fever in India.[12] The award was given by the Union Health Minister, Harsh Vardhan.[5] In 2012, she was awarded the ICMR's Dr. T Ram Chandra Rao Award by the Ministry of Health and Family Welfare, Government of India.[7]

She has received many other awards such as:

References

  1. ↑ Bhardwaj, Shalini (2 April 2022). "ICMR played crucial role in India's COVID-19 fightback: Scientist". Asian News International.
  2. ↑ Faisal, Mohd (2 April 2022). "भारत ने कोरोना पर पाया काबू, वैज्ञानिक प्रज्ञा यादव ने कहा- ICMR ने इस लड़ाई में निभाई महत्वपूर्ण भूमिका" (in Hindi). Dainik Jagaran.
  3. ↑ Rana, Chahat (13 May 2022). "The hits and misses of India's ambitious COVID-19 genome sequencing project". The Caravan.
  4. ↑ Biraia Jaiswal, Pooja (13 March 2022). "Hope for a better tomorrow reigned supreme at THE WEEK's Women's Day event". The Week.
  5. 1 2 "Harsh Vardhan honours three National Institute of Virology scientists". Indian Express. 20 October 2019.
  6. 1 2 3 4 5 6 7 8 9 10 "NIV scientist awarded for work on vaccine development in India". The Times of India. 1 April 2022.
  7. 1 2 3 4 5 "Pragya D Yadav". Naas.org.in. National Academy of Agricultural Sciences. 2021.
  8. ↑ "Vaccine women". Spectrum. Chandigarh: The Sunday Tribune. 8 May 2022.
  9. ↑ "Pragya D. Yadav, ICMR National Institute Of Virology Pune, MH". Medifind.com. Retrieved 2 August 2022.
  10. ↑ "Presence of 'bat coronavirus' found in Kerala, Tamil Nadu, says ICMR study". The Financial Express (India). 15 April 2020.
  11. ↑ "NAMS Orations Awards - 2022-2023" (PDF). Nams-India.in. 23 May 2022.
  12. ↑ "ICMR Awards & Prizes 2017 & 2018" (PDF). ICMR. p. 15.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.